Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish

Frontiers in Pharmacology

Volumn 5 JUN, Issue , 2014, Pages 1-14

  Bruni, Giancarlo ^a   Lakhani, Parth ^a   Kokel, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; NEW DRUG; PSYCHOTROPIC AGENT;

ANIMAL BEHAVIOR; ANIMAL USE; ARTICLE; AUTOMATION; BIOINFORMATICS; BLOOD BRAIN BARRIER; DRUG ACTIVITY; DRUG APPROVAL; DRUG CLASSIFICATION; DRUG DETERMINATION; DRUG MECHANISM; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; GENETIC MODEL; HIGH THROUGHPUT SCREENING; HISTORY OF MEDICINE; MOUSE PHENOME DATABASE; NONHUMAN; PHENOTYPIC VARIATION; ROBOTICS; TOXICITY AND INTOXICATION; TRANSLATIONAL RESEARCH; ZEBRA FISH; ZEBRAFISH NEUROPHENOME DATABASE;

EID: 84904765812     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00153     Document Type: Article

References (96)

1. Alexander, G. C., Gallagher, S. A., Mascola, A., Moloney, R. M. & Stafford, R. S. Increasing off-label use of antipsychotic medications in the United States, 1995-2008. Pharmacoepidemiol Drug Saf 20, 177-184(2011).
2. Gu, Q., Dillon, C. F. & Burt, V. L. Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief1-8 (2010).
3. Alonso, J. et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl 109, 55-64 (2004).
4. Mojtabai, R. & Olfson, M. National trends in long-term use of antidepressant medications: results from the U.S. National Health and Nutrition Examination Survey. J Clin Psychiatry 75,169-177 (2014).
5. Olfson, M., Kroenke, K., Wang, S. & Blanco, C. Trends in office-based mental health care provided by psychiatrists and primary care physicians. J Clin Psychiatry 75, 247-253 (2014).
6. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. NatRevDrugDiscov9, 203-214 (2010).
7. Irwin, S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacology (Berl.) 13, 222-257(1968).
8. Tecott, L. H. & Nestler, E. J. Neurobehavioral assessment in the information age. Nature Neuroscience 7, 462-466 (2004).
9. Sneader, W. Drug Discovery. (John Wiley & Sons, 2005).
10. Kokel, D. & Peterson, R. T. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish. Brief Funct Genomic Proteomic 7, 483-490 (2008).
11. Enna, S. J. & Williams, M. Challenges in the search for drugs to treat central nervous system disorders. J. Pharmacol. Exp. Ther. 329, 404-411 (2009).
12. Schadt, E. E., Friend, S. H. & Shaywitz, D. A. A network view of disease and compound screening. Nat Rev Drug Discov8, 286-295 (2009).
13. Maher, A. R. et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA 306,1359-1369 (2011).
14. Javitt, D. C., Spencer, K. M., Thaker, G. K., Winterer, G. & Hajós, M. Neurophysiological biomarkers for drug development in schizophrenia. Nat Rev Drug Discov 7, 68-83 (2008).
15. Chouinard, G. The search for new off-label indications for antidepressant, antianxiety, antipsychotic and anticonvulsant drugs. J Psychiatry Neurosci 31,168-176 (2006).
16. FDALabel. at
17. Backman, T. W. H., Cao, Y. & Girke, T. ChemMine tools: an online service for analyzing and clustering small molecules. Nucleic Acids Res. 39, W486-91 (2011).
18. Cao, Y., Charisi, A., Cheng, L.-C, Jiang, T. & Girke, T. ChemmineR: a compound mining framework for R. Bioinformatics 24,1733-1734 (2008).
19. Sneader, W. Drug Prototypes and Their Exploitation. (Wiley, 1996).
20. Prober, D. A., Rihel, J., Onah, A. A., Sung, R. J. & Schier, A. F. Hypocretin/Orexin Overexpression Induces An Insomnia-Like Phenotype in Zebrafish. J. Neurosci. 26,13400-13410 (2006).
21. Rihel, J. et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327, 348-351 (2010).
22. Yokogawa, T. et al. Characterization of sleep in zebrafish and insomnia in hypocretin receptor mutants. PLoSBiol. 5, e277 (2007).
23. Zhdanova, I. V. Sleep in zebrafish. Zebrafish 3, 215-226 (2006).
24. Prober, D. A. et al. Zebrafish TRPA1 channels are required for chemosensation but not for thermosensation or mechanosensory hair cell function. J. Neurosci. 28,10102-10110 (2008).
25. Agetsuma, M. et al. The habenula is crucial for experience-dependent modification of fear responses in zebrafish. Nature Neuroscience 13,1354-1356 (2010).
26. Mathuru, A. S. et al. Chondroitin fragments are odorants that trigger fear behavior in fish. Curr. Biol. 22,538-544(2012).
27. Speedie, N. & Gerlai, R. Alarm substance induced behavioral responses in zebrafish (Danio rerio). Behav. Brain Res. 188,168-177 (2008).
28. Lee, A. et al. The habenula prevents helpless behavior in larval zebrafish. Curr. Biol. 20, 2211-2216 (2010).
29. Gahtan, E., Tanger, P. & Baier, H. Visual prey capture in larval zebrafish is controlled by identified reticulospinal neurons downstream of the tectum. J. Neurosci. 25, 9294-9303 (2005).
30. Bianco, I. H., Kampff, A. R. & Engert, F. Prey capture behavior evoked by simple visual stimuli in larval zebrafish. FrontSyst Neurosci 5,101 (2011).
31. Del Bene, F. et al. Filtering of visual information in the tectum by an identified neural circuit. Science 330, 669-673 (2010).
32. Darrow, K. O. & Harris, W. A. Characterization and development of courtship in zebrafish, Danio rerio. Zebrafish 1, 40-45 (2004).
33. Valente, A., Huang, K. H., Portugues, R. & Engert, F. Ontogeny of classical and operant learning behaviors in zebrafish. Learn. Mem. 19,170-177 (2012).
34. Emran, F. et al. OFF ganglion cells cannot drive the optokinetic reflex in zebrafish. Proc. Natl. Acad. Sci. U.S.A. 104, 19126-19131 (2007).
35. Gleason, M. R. et al. The transmembrane inner ear (Tmie) protein is essential for normal hearing and balance in the zebrafish. Proc. Natl. Acad. Sci. U.S.A. 106, 21347-21352 (2009).
36. Low, S. E. et al. Touch responsiveness in zebrafish requires voltage-gated calcium channel 2.1b. J. Neurophysiol. 108,148-159 (2012).
37. Low, S. E. et al. touché Is required for touch-evoked generator potentials within vertebrate sensory neurons. J. Neurosci. 30, 9359-9367 (2010).
38. Low, S. E. et al. TRPM7 is required within zebrafish sensory neurons for the activation of touchevoked escape behaviors. J. Neurosci. 31,11633-11644 (2011).
39. Mahabir, S., Chatterjee, D., Buske, C. & Gerlai, R. Maturation of shoaling in two zebrafish strains: a behavioral and neurochemical analysis. Behav. Brain Res. 247,1-8 (2013).
40. Qin, M., Wong, A., Seguin, D. & Gerlai, R. Induction of Social Behavior in Zebrafish: Live Versus Computer Animated Fish as Stimuli. Zebrafish 140227075646004 (2014). doi:10.1089/zeb.2013.0969
41. Pérez-Escudero, A. & de Polavieja, G. G. Collective animal behavior from Bayesian estimation and probability matching. PLoS Comput. Biol. 7, e1002282 (2011).
42. Stewart, A. et al. Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 62,135-143(2012).
43. Arganda, S., Pérez-Escudero, A. & de Polavieja, G. G. A common rule for decision making in animal collectives across species. Proc. Natl. Acad. Sci. U.S.A. 109, 20508-20513 (2012).
44. Stewart, A. M. & Kalueff, A. V. The behavioral effects of acute Δ -tetrahydrocannabinol and heroin (diacetylmorphine) exposure in adult zebrafish. Brain Res. 1543,109-119 (2014).
45. Williams, L. R. et al. Behavioral and physiological effects of RDX on adult zebrafish. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 155, 33-38 (2012).
46. Kyzar, E. etal. Behavioral effects of bidirectional modulators of brain monoamines reserpine and damphetamine in zebrafish. Brain Res. 1527,108-116 (2013).
47. Stewart, A. et al. Behavioral effects of MDMA (ecstasy) on adult zebrafish. Behav Pharmacol 22, 275-280(2011).
48. Kyzar, E. J. et al. Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology. Progress in Neuro-Psychopharmacology and Biological Psychiatry 37,194-202 (2012).
49. Grossman, L. et al. Effects of piracetam on behavior and memory in adult zebrafish. Brain Res. Bull. 85,58-63(2011).
50. Robinson, K. S. L. et al. Psychopharmacological effects of acute exposure to kynurenic acid (KYNA) in zebrafish. Pharmacology Biochemistry and Behavior 108, 54-60 (2013).
51. Cachat, J. et al. Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS ONE 6, e17597(2011).
52. Wyart, C. et al. Optogenetic dissection of a behavioural module in the vertebrate spinal cord. Nature 461, 407-410 (2009).
53. Kokel, D. et al. Identification of Nonvisual Photomotor Response Cells in the Vertebrate Hindbrain. J. Neurosci. 33, 3834-3843 (2013).
54. Kokel, D. et al. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nature Publishing Group 6, 231-237 (2010).
55. Dudley, J. T., Schadt, E., Sirota, M., Butte, A. J. & Ashley, E. Drug discovery in a multidimensional world: systems, patterns, and networks. J Cardiovasc TranslRes 3, 438-447 (2010).
56. Adatto, I., Lawrence, C., Thompson, M. & Zon, L. I. A new system for the rapid collection of large numbers of developmentally staged zebrafish embryos. PLoS ONE 6, e21715 (2011).
57. Burgess, H. A. & Granato, M. Modulation of locomotor activity in larval zebrafish during light adaptation. Journal of Experimental Biology 210, 2526-2539 (2007).
58. Pardo-Martin, C. et al. High-throughput hyperdimensional vertebrate phenotyping. Nat Comms 4, 1467 (2013).
59. Pardo-Martin, C. et al. High-throughput in vivo vertebrate screening. Nature Publishing Group 7, 634-636(2010).
60. Engert, F. Fish in the matrix: motor learning in a virtual world. Front Neural Circuits 6,125 (2012).
61. Ahrens, M. B. et al. Brain-wide neuronal dynamics duringmotor adaptation in zebrafish. Nature 1-9 (2012). doi:10.1038/nature11057
62. Wittmann, C. et al. Facilitating drug discovery: an automated high-content inflammation assay in zebrafish. J Vis Exp e4203-e4203 (2012). doi:10.3791/4203
63. Burgess, H. A., Schoch, H. & Granato, M. Distinct retinal pathways drive spatial orientation behaviors in zebrafish navigation. Curr. Biol. 20, 381-386 (2010).
64. Burgess, H. A. & Granato, M. Sensorimotor gating in larval zebrafish. J. Neurosci. 27, 4984-4994 (2007).
65. Burgess, H. A., Johnson, S. L. & Granato, M. Unidirectional startle responses and disrupted left-right co-ordination of motor behaviors in robo3 mutant zebrafish. Genes Brain Behav. 8, 500-511 (2009).
66. Jain, R. A., Wolman, M. A., Schmidt, L. A., Burgess, H. A. & Granato, M. Molecular-genetic mapping of zebrafish mutants with variable phenotypic penetrance. PLoS ONE 6, e26510 (2011).
67. Fernandes, A. M. et al. Repor tDeep Brain Photoreceptors Control Light-Seeking Behavior in Zebrafish Larvae. Current Biology 22, 2042-2047 (2012).
68. Wolman, M. A., Jain, R. A., Liss, L. & Granato, M. Chemical modulation of memory formation in larval zebrafish. Proc. Natl. Acad. Sci. U.S.A. 108,15468-15473 (2011).
69. Ahrens, M. B., Orger, M. B., Robson, D. N., Li, J. M. & Keller, P. J. Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nature Publishing Group 10, 413-420 (2013).
70. Muto, A., Ohkura, M., Abe, G., Nakai, J. & Kawakami, K. Real-time visualization of neuronal activity during perception. Curr. Biol. 23, 307-311 (2013).
71. Satou, C. et al. Transgenic tools to characterize neuronal properties of discrete populations of zebrafish neurons. Development 140, 3927-3931 (2013).
72. Portugues, R., Feierstein, C. E., Engert, F. & Orger, M. B. Whole-Brain Activity Maps Reveal Stereotyped, Distributed Networks for Visuomotor Behavior. Neuron 81,1328-1343 (2014).
73. Chang, T.-Y., Pardo-Martin, C., Allalou, A., Wählby, C. & Yanik, M. F. Fully automated cellularresolution vertebrate screening platform with parallel animal processing. Lab Chip 12, 711-716 (2012).
74. Pardo-Martin, C. et al. High-throughput in vivo vertebrate screening. Nature Publishing Group 7, 634-636(2010).
75. Marzullo, T. C. & Gage, G. J. The SpikerBox: a low cost, open-source bioamplifier for increasing public participation in neuroscience inquiry. PLoS ONE 7, e30837 (2012).
76. Alper, J. Biotech in the basement. Nat. Biotechnol. 27,1077-1078 (2009).
77. Kalueff, A. V. et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10, 70-86 (2013).
78. Green, J. et al. Automated high-throughput neurophenotyping of zebrafish social behavior. J. Neurosci. Methods 210, 266-271 (2012).
79. Kyzar, E. et al. The Zebrafish Neurophenome Database (ZND): a dynamic open-access resource for zebrafish neurophenotypic data. Zebrafish 9, 8-14 (2012).
80. Maddatu, T. P., Grubb, S. C., Bult, C. J. & Bogue, M. A. Mouse Phenome Database (MPD). Nucleic Acids Res. 40, D887-94 (2012).
81. Lamb, J. The Connectivity Map: a new tool for biomedical research. Nat. Rev. Cancer 7, 54-60 (2007).
82. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313,1929-1935 (2006).
83. Kokel, D. et al. Photochemical activation of TRPA1 channels in neurons and animals. Nat. Chem. Biol. 9, 257-263 (2013).
84. Levitz, J. et al. Optical control of metabotropic glutamate receptors. Nature Neuroscience 16, 507-516(2013).
85. Janovjak, H., Szobota, S., Wyart, C., Trauner, D. & Isacoff, E. Y. A light-gated, potassium-selective glutamate receptor for the optical inhibition of neuronal firing. Nature Neuroscience 13,1027-1032 (2010).
86. Szobota, S. et al. Remote control of neuronal activity with a light-gated glutamate receptor. Neuron 54, 535-545 (2007).
87. Baraban, S. C., Dinday, M. T. & Hortopan, G. A. Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment. Nat Comms 4, 2410 (2013).
88. Hwang, W. Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227-229 (2013).
89. Hwang, W. Y. et al. Heritable and precise zebrafish genome editing using a CRISPR-Cas system. PLoS ONE8, e68708(2013).
90. Auer, T. O., Duroure, K., De Cian, A., Concordet, J.-P. & Del Bene, F. Highly efficient CRISPR/Cas9-mediated knock-in in zebrafish by homology-independent DNA repair. Genome Res. 24,142-153 (2014).
91. Bai, Q., Garver, J. A., Hukriede, N. A. & Burton, E. A. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res. 35, 6501-6516 (2007).
92. Olson, B. D., Sgourdou, P. & Downes, G. B. Analysis of a zebrafish behavioral mutant reveals a dominant mutation in atp2a1/SERCA1. Genesis 48, 354-361 (2010).
93. Baraban, S. C., Taylor, M. R., Castro, P. A. & Baier, H. Pentylenetetrazol induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131, 759-768 (2005).
94. Jeong, J.-Y. et al. Functional and developmental analysis of the blood-brain barrier in zebrafish. Brain Res. Bull. 75, 619-628 (2008).
95. Landis, S. C. et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490,187-191 (2012).
96. Howe, K. et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498-503 (2013).